Lymphoma Cancer
Phase II Study of VcR-CVAD witih Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma [ECOG 1405]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma [ECOG 1F05]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
Randomized Phase III Trial of ABVD vs. Stamford V Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease with 0-2 Risk Factors [ECOG 2496]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.
Responsive-Adapted Therapy for Aggressive non-Hodgkin's Lymphomas Based on Early (18F) FDG-PET Scanning [ECOG 3404]
Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.